We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Apax Global Alpha Limited | LSE:APAX | London | Ordinary Share | GG00BWWYMV85 | ORD NPV |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.60 | 0.44% | 138.20 | 137.40 | 138.60 | 138.60 | 137.40 | 137.40 | 602,497 | 16:35:15 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Trust,ex Ed,religious,charty | 70.18M | 53.48M | 0.1091 | 12.65 | 674.46M |
Date | Subject | Author | Discuss |
---|---|---|---|
07/5/2024 10:44 | every little helps, and I think the 23% uplift is more significant than the 1p it represents. The question is can you apply such a % uplift across the portfolio? This is a sale to KKR Asia, so its a more specialist fund within the PE family. Better than an internal sale to other Apax funds, but not as strong as a trade sale or IPO in terms of market pricing. Any realisation is to be welcomed while we continue to trade at such a discount | makinbuks | |
07/5/2024 09:20 | Profitable exit from Healthium investment which adds [wait for it...] c.£0.01 to Adjusted NAV at 31/3/2024. Not exactly an excuse for cracking open the champagne but every little helps I suppose. Apax IX agrees to sell Healthium - | speedsgh | |
02/5/2024 11:04 | From today's update: "Following materially deteriorating trading at Vyaire during Q1, AGA has taken a €24m writedown on its value across the Private Equity and Debt portfolios, reducing AGA's Private Equity exposure to Vyaire to c.€5m and Debt exposure to Vyaire's first lien loan to €12m." Vyaire Medical - APAX valuation of Vyaire equity holding at 31/12/23 was EUR 27.0m; debt was EUR 14.0m. Combined valuation was thererfore EUR 41.0m. From Q1 factsheet Vyaire debt has been written down to EUR 11.8m (-2.2m). From today's update we know that combined valuation of equity/debt has been written down to EUR 24m so looks like the equity has been written down from EUR 27.0m to c. EUR 12.2m (-55%). FY23 results presentation - Q1 2024 results presentation - | speedsgh | |
02/5/2024 10:33 | Do we know anything about the rogue detractor? "... Q1 performance was negatively impacted by developments in one of the Private Equity portfolio companies..." | makinbuks | |
02/5/2024 10:28 | The last bullet point: "The Board is reassessing the Company's capital allocation policy and will update on progress of the review at the Capital Markets Day on 26 June 2024" This can mean buybacks or a dividend cut. Difficult to know but adds a layer of uncertainty. | feddie | |
02/5/2024 10:01 | Agreed speedsgh. Out of fashion and so good value across the whole sector. Take the attractive dividend yield and wait for the sector to re-rate. Are there any funds allowing us to buy the sector? | lowtrawler | |
02/5/2024 09:20 | NAV per share down 16% in both EUR/GBP since its peak in Q3/Q4 2021. Share price down approx. 37% over same time period. Has moved from low single digit discount to the current 34% discount. Opportunity for the patient who are happy to wait for the NAV to return to growth & discount to narrow? To be fair you could probably buy the sector at present and make a decent return over the medium term. | speedsgh | |
02/5/2024 09:03 | ~ Q1 adjusted NAV per share EUR 2.54; -3.1% (GBP 2.17; -4.4%) ~ Total NAV return -0.5% (-1.9% constant currency) * Total return private equity -1.7% (-3.2% constant currency) * Total return debt investments +3.5% (+1.8% constant currency) * Total return derived equity +13.6% (+11.8% constant currency) Quarterly Results to 31 March 2024 - Ralf Gruss, Partner at Apax and a member of the AGA investment committee, said: "While Q1 performance was negatively impacted by developments in one of the Private Equity portfolio companies, we believe AGA's overall portfolio remains in good shape, offering solid value growth for shareholders. We are seeing continued momentum with several new private equity investments since the beginning of the year and there is a good pipeline of both new investments and exits. We believe the current share price significantly undervalues the Company's Private Equity holdings." | speedsgh | |
24/4/2024 13:01 | Lots of activity by APAX (see RNS). The discount is on the ridiculous side at 37% but what's staggering is if you take away the credit it's close to 50%. | mrscruff | |
18/4/2024 06:32 | Unfortunate drop ahead of lower rate cuts ahead of European inflation. I have added some more as part of a diversified portfolio of multi-assets. | mrscruff | |
10/4/2024 21:50 | It went down on US high inflation news today and APAX has a high allocation to US. I have also added. The downside protected by the credit income and sector wide discount on equity. We do have to wait though and bank the dividend in the mean time. European central rate cuts will be interesting as this is a European company with US exposure 🤔 This is a lower risk investment than other Private Equity and with a high reward of what 40% over the next 18 months? Many will not be able to wait. Not one for FOMO lovers, but patience. | mrscruff | |
10/4/2024 19:08 | Actually more like sideways after going xd. | its the oxman | |
10/4/2024 14:19 | Not sure it won't go lower but got to be in the cheap zone at this level. | its the oxman | |
10/4/2024 14:19 | So why's it going down?!! | brucie5 | |
10/4/2024 14:17 | Added c.143p. | its the oxman | |
10/4/2024 08:33 | Added c.145p | its the oxman | |
05/3/2024 11:26 | No surprises in todays results. Doing exactly what it says on the tin. Derivative portfolio delivering exceptional results and allowing the dividend policy to be continued while realisations from PE are reinvested. Huge discount will narrow at some point. Patience required in the meantime | makinbuks | |
12/2/2024 15:40 | Yep , still seems a bargain when close to 150p. | its the oxman | |
11/2/2024 13:48 | free stock charts from uk.advfn.com | skyship | |
11/2/2024 13:39 | Divi at 5% Of NAV delivers 11.35p, ie a yield at 153p of 7.42%. "Against an uncertain market backdrop, AGA's performance remained resilient driven primarily by value creation in the Private Equity portfolio and strong returns from the Company's debt investments. Over the last five years AGA has delivered a total annualised return of c.12% and returned nearly EUR300m in dividends to shareholders. This is testament to the strength of AGA's portfolio and the Apax Funds' 'all-weather' investment strategy." Does rather suggest this is a safe PE High-yielder trending down to the lows of its trading range. I'll be looking for a cheap offer to be on-board soon... | skyship | |
09/2/2024 12:27 | Estimated Adjusted NAV as at 31 December 2023 - AGA estimates its Adjusted NAV2 as at 31 December 2023 to be c.€1,288m (FY22 c.€1,299m) or €2.62 cents per share / £2.27 pence per share. Income from the portfolio and gains were largely offset by c.€65m paid in dividends to shareholders during the year and the impact of FX due to the EUR strengthening against the USD. FY23 Total Adjusted NAV Return was 4.1% (6.1% constant currency) with Q4 Total Return of 1.9% (4.5% constant currency). Details on the composition and valuation of the AGA portfolio as at 31 December 2023 (which may differ to those shown in the table below due to the various holding structures through which AGA invests) will be included in AGA's 2023 Annual Results, being released on 5 March 2024. Commenting on the performance, Ralf Gruss, Partner at Apax and a member of the AGA Investment Committee, said: "Despite weaker economic activity in 2023, there was good momentum across the Private Equity portfolio with deal activity picking up in the second half of the year as more compelling investment opportunities emerged. The Apax Funds' strategy is not predicated on continued market tailwinds and its foundation focuses on buying right at entry and accelerating business performance during the funds' ownership to generate alpha. We believe it is a strategy well suited for the current environment." | speedsgh | |
16/1/2024 14:04 | @nexusltd I do factor in dividend distributed from NAV on relative performance. The floating rate private credit was not a huge drag on performance during the good times and should now be a benefit with higher lending rates. Even with this drag there is a 40% discount on the equity. | mrscruff |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions